Rafael Pharmaceuticals to Present New Pancreatic Cancer and Biliary Tract Cancer Data featuring CPI-613® (Devimistat) at the American Society of Clinical Oncology (ASCO) 2021 Virtual Scientific Program

NEXT STORY
Growing Focus of Pharma Companies on Developing Drugs for COVID-19 Treatment to Foster the Growth of Antiviral Therapy Market during Pandemic – Exclusive Report [Pages-150] by Research Dive
PREV STORY
Skylight Health Group Announces Closing of $13.8 Million Bought Deal Financing and Share Consolidation
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Syneos Health to Share Strategies Designed to Meet the Needs of Patients, Payers and Regulators at DIA Global Annual Meeting

Company to Host Annual Site Appreciation Reception to Recognize the Critical Role of Clinical ...

author_avatar
NASDAQ Market News

Atara Biotherapeutics Announces Third Quarter 2018 Financial Results and Recent Operational Progress

SOUTH SAN FRANCISCO, Calif., Nov. 06, 2018 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq: ...

author_avatar
NASDAQ Market News

Verona Pharma Initiates Phase 2 Clinical Trial Evaluating Nebulized RPL554 as Add-on to Dual Bronchodilator Therapy for COPD Maintenance Treatment

This three-way crossover study will inform design of pivotal Phase 3 trials  Top line ...

author_avatar
NASDAQ Market News